Noom’s Post

As we move into commercialization of our VMS+ technology in 2024, Ventripoint is getting noticed. Canada Health Watch, read by key health care administrators and care-givers, states "Ventripoint has emerged as a standout, with some truly breakthrough tech that uses AI to improve patient care, and brings with it the potential to lower health system costs.. . " Getting such attention is a testament to the effectiveness of our technology, the team that built it and, I believe, a taste of what's ahead. 🙏 Read the full article here: https://lnkd.in/gy-sYHPR

🚀 The healthcare diagnostic landscape is on the brink of a transformative journey. Self-testing and AI are set to revolutionize diagnostics by 2024, as detailed in a recent Nasdaq article. The future shines bright, especially in terms of women's health. Imagine the impact of personalized diagnostic tools at your fingertips—empowering individuals, women especially, to proactively manage their well-being. The blend of self-testing tech and AI could mean early disease detection, better treatments, and reduced healthcare system burdens. All while moving towards a model that prioritizes remote and virtual care. 💡 Yet, as we step into this new era, challenges like regulatory barriers, privacy issues, and technology accuracy need our focus and action. How do you envision this influencing women's health? Share your insights on how these trends will reshape the healthcare industry, with a keen eye on women's health. 💬 For more information on our database of companies already pioneering in this space, check out our comment section for the link. 👇 #HealthTech #WomensHealth #AIinHealthcare 🔗 Source: https://lnkd.in/gVmHC3wd

💡 The integration of AI and other health technologies, ethical considerations, regulatory challenges, and the emergence of new treatment avenues offer both opportunities and challenges for stakeholders. Check out this weeks Wrap Up for the latest curated new in the healthcare industry! Have a good weekend, All!

Clinical Data isn't just numbers; it's the story of patient health unfolding in real time. With the rise of Real-World Data (RWD) in clinical research, every patient interaction holds the potential to improve treatments and accelerate drug approvals. RWD leverages everyday health experiences, from electronic health records to wearable tech, giving researchers a treasure trove of information to enhance clinical trials and patient care. As we embrace this data-driven era, the question remains: How will these insights transform the clinical trial landscape?

Leveraging real-world data is a critical component of building effective lifespan solutions. At Rejuve.Bio, this aligns with our commitment to integrate diverse data sources, working with our partner Rejuve.AI, and enhancing our AI-driven approaches to decipher complex aging patterns and optimize individualized aging interventions. https://lnkd.in/gqRew7hs

It is going to be interesting to watch #FDA approvals for #AI platforms. Undoubtedly this will change #healthcare and #patient outcomes. I will be curious to see how tools like this that are such game changers for patients are equitably scaled into #hospitals. Dr. Dan Weberg, Michael Hasselberg, Rich G Kenny,....thoughts?

The interactive walkway provides fit-for-purpose fall-risk biomarkers in the elderly: Comparison of zolpidem and suvorexant Clinical Trial Results: Interactive Walkway for Fall-Risk Biomarkers in the Elderly Key Findings: Study compared zolpidem and suvorexant in elderly subjects to assess the sensitivity of the Interactive Walkway (IWW) in measuring walking adaptability and fall risk. Results indicated that zolpidem led to decreased performance in walking adaptability, Timed-Up-and-Go test, and body sway, while suvorexant had minimal impact on IWW measurements. IWW successfully quantified the effects of the two drugs and showed sensitivity in assessing dynamic balance and potential fall risk in early clinical drug development. Practical Solutions and Value: Implementing AI-driven platforms like DocSym can consolidate clinical standards and research, making knowledge easily accessible for clinicians and enhancing treatment development. Mobile apps supporting scheduling, treatment monitoring, and telemedicine can streamline operations, manage patient care, and expand services digitally in today’s healthcare environment. AI can enhance clinic workflows, improve patient outcomes, and reduce routine paperwork, ultimately benefiting both healthcare providers and patients. Learn more about how we can help at aidevmd.com. https://lnkd.in/gACpU3xU #ClinicalTrials #AIinHealthcare #MedicalAI #HealthTech #DigitalHealth #PatientCareAI #AIResearch #MedicalInnovation #BioTech #AIforGood #HealthcareData #AIinMedicine #PharmaAI #ClinicalData #HealthAI #AIHealthSolutions #PrecisionMedicine #AIandHealth #ClinicalAnalytics #AIDiagnostics

Witnessing a milestone in medical diagnostics: VELLAP SCAN - a joint brand between SENOVA and Flowify AI. ✅ Quantifying rapid tests with just the smartphone. Eight products are now ready for use! In April last year, I got to know Hans Hermann Söffing, the CEO of Senova Gesellschaft für Biowissenschaft und Technik mbH, a leading LFA production company in Germany. Only five months later, in November 2023, we launched a joint brand with our first product: VELLAP DDimer, powered by our Flowify AI. A pioneering step in the digitalization of LFAs. 🔢 Just two months later, this week, we launched an online shop with eight products that are ready to use for medical professionals. Order online, test at home and be assured to have the most advanced reader in the palm of your hands. It makes testing more accessible, efficient and precise. The current IVD products are: D-Dimer, Troponin I, Ferritin, TSH, Celiac Disease, Strep A, Influenza A/B, Legionella. ✅ Six additional products are currently for research use only but are in the pipeline to be launched soon as well: CRP, Diphtheria, Vitamin D, AFB, EFB, PVL, PBP2a - I will keep you posted! In just a short period, SENOVA and Flowify AI have transformed LFA quantification with VELLAP SCAN. There’s a lot more to come - stay tuned! Thanks SENOVA for this exciting journey together! 🙏 Are you ready for the future of medical diagnostics? Here’s the link to it:  https://www.vellap.shop/ #lateralflow #medicaldevices #HealthcareInnovation #DigitalHealth

🚀 OM1, Inc. has just launched its Registries Center of Excellence, set to transform the landscape of patient registries and clinical research. Here’s why you should explore this exciting development: 1️⃣ Innovative Technology: Utilizing AI and real-world data to enhance the accuracy and efficiency of patient registries. 2️⃣ End-to-End Support: Offering expert consultation throughout the entire registry lifecycle, from design to data analysis. 3️⃣ Collaborative Hub: Providing a space for collaboration, education, and training for healthcare professionals and researchers. Dive into the details of this pioneering initiative here. 🌟 - https://lnkd.in/eCux6etf #HealthcareInnovation #ClinicalResearch #AIinHealthcare #RWD #PatientRegistries #RealWorldEvidence #HealthData #MedicalResearch #DigitalHealth #HealthcareData #BiotechInnovation #HealthIT #DataScience #ClinicalOutcomes #PrecisionMedicine #PatientCare

From electronic health records to wearables and patient reported data, every step of the patient journey can offer critical insights for researchers working to improve outcomes. At Inspire, we combine all of this data to provide an exclusive understanding of the patient experience. Visit our website and contact our team for more info on how we can offer commercial and clinical insights you can’t get anywhere else. https://ow.ly/Yzmr50PIu7Z #RWE #RealWorldEvidence #HEOR #EHR #PatientInsights